Stay updated on GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a Locations section with California, Colorado, Florida, Illinois, Kentucky, Louisiana, New Hampshire, and Virginia; removed HHS Vulnerability Disclosure and the listed state location sections, and updated the revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-24T15:19:29.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.3.2, replacing the previous v3.2.0. No study-specific information appears to be changed.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:05.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding status notice on the page was removed. This change does not affect any study details, eligibility criteria, or results reporting; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:26:28.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    No substantive changes detected to the Study Details page for NCT03417882; core sections like eligibility criteria, study design, and participating locations appear unchanged.
    Difference
    0.5%
    Check dated 2025-10-27T20:53:34.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T07:53:52.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Updated the page to reflect a new version (v3.1.0) and removed the old version tag (v3.0.2).
    Difference
    0.1%
    Check dated 2025-09-29T04:17:57.000Z thumbnail image

Stay in the know with updates to GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GRN-1201 & Pembrolizumab in Metastatic NSCLC Clinical Trial page.